- Home >
- Life Sciences >
- Pharmaceutical >
Pharmaceutical Industry Analysis and Statistics (since 2008 - p20)
Refine results by
Top countries
Publication dates
- All
- Since 2009 (5 639)
- Since 2008
All countries
Popular tags
All premium reports for Pharmaceutical Industry Analysis and Statistics (since 2008 - p20)
571-600 of 6 476 Premium Reports from 57 Publishers
Lebanon Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Lebanon remains a strong pharmaceutical market in the Middle East and Africa (MEA) region. In BMI?supdated Business Environment Ratings for Q309, Lebanon holds a respectable 13th position. Thecountry?s pharmaceutical market was worth US$500mn in 2008, and is expected to grow to be worthUS$517mn in 2 ...
Industries : Healthcare, Pharmaceutical
Croatia Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Of the 20 markets measured in BMI?s Q309 Pharmaceuticals & Healthcare Business EnvironmentRankings for Central and Eastern Europe (CEE), Croatia is placed 10th, reflecting the country?s middlerankingattractiveness for multinational companies. While the Croatian market is making great efforts toalign ...
Industries : Healthcare, Pharmaceutical
Germany Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Germany?s drug market expenditure reached a value of EUR40.6bn (US$59.7bn) in 2008. The value ofthe country?s pharmaceutical market is forecast to reach EUR48.6bn (US$61.6bn) by 2013, representing acompound annual growth rate (CAGR) of 3.69% in local currency terms.Germany places 2nd in our Western ...
Industries : Healthcare, Pharmaceutical
Greece Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Greece?s uncontrolled growth in drug expenditure, which increased by 59% between 2004 and 2008, hasled the country to rank among the highest per capita spenders in Europe. While a proportion of this figureis likely attributable to the country?s parallel export market, cost effective use of health fu ...
Industries : Healthcare, Pharmaceutical
Philippines Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
The Philippines remains ranked as the 11th most attractive pharmaceutical market among 15 majorcountries in the Asia Pacific region, according to BMI?s Business Environment Rankings for Q309.Nevertheless, BMI expects the country to improve this position over the next five-year period as themarket ma ...
Industries : Healthcare, Pharmaceutical
Singapore Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
In BMI?s Business Environment Rankings (BER) matrix for Q309, Singapore slipped from fourth tosixth position out of the 15 key countries in the Asia Pacific region, in line with worsening economicconditions and their impact on the pharmaceutical market growth and exports in the country. WhileSingapo ...
Industries : Healthcare, Pharmaceutical
Bangladesh Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Out of the 15 key markets surveyed in BMI?s Pharmaceuticals & Healthcare Business EnvironmentRankings, Bangladesh is placed in 13th position, and can be found above Pakistan and Vietnam, the latterbeing judged the least attractive proposition for investment. Bangladesh?s ascent in the current rating ...
Industries : Healthcare, Pharmaceutical
Canada Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
For BMI?s Pharmaceutical and Healthcare Q309 Report for Canada, we believe the total drug marketvalue will increase from US$22.4bn in 2008 to US$37.2bn by 2013, representing a compound annualgrowth rate (CAGR) of 10.7% in US dollar terms. We believe that the generic and patented drug marketswill rea ...
Industries : Healthcare, Pharmaceutical
AmerisourceBergen Corporation - SWOT Analysis
- $ 125
- June 2009
Datamonitor's AmerisourceBergen Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. AmerisourceBergen Corporation - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analy ...
Industries : Healthcare, Pharmaceutical
Estonia Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
In BMI?s Business Environment Ranking matrix for Q309, Estonia remains seventh out of the 20 majormarkets surveyed in the Emerging Europe region. The country?s overall pharmaceutical rating figurecontinued to fall over the past few quarters, in line with worsening economic conditions and their impac ...
Industries : Healthcare, Pharmaceutical
India Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
For the Q309 update of this report, BMI has maintained it forecasts for India?s US$14.23bnpharmaceutical market as no new sales figures have emerged and the country?s macroecominc projectionshave remained static. We expect combined sales of patented products, generic drugs and over-the-counter(OTC) ...
Industries : Healthcare, Pharmaceutical
Puerto Rico Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Puerto Rico?s pharmaceutical market is showing strong growth in nominal terms, but high inflation in theeconomy will erode many of these gains. BMI expects the Puerto Rican drug market to increase fromUS$2.9bn in 2008 to US$4bn by 2013, representing a compound annual growth rate (CAGR) of 6.68% inUS ...
Industries : Healthcare, Pharmaceutical
Uzbekistan Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Uzbekistan?s relative economic isolation and lack of development have served to isolate the country ? onpaper at least ? from many of the negative effects of the global financial crisis, and its pharmaceuticalmarket is expected to remain one of the most resilient of the 20 Central and Eastern Europe ...
Industries : Healthcare, Pharmaceutical
IT Software Tools for Life Science and Drug Discovery R&D: Bioscience, Biotechnology, Pharmaceutical Company and Institute?s
- $ 1 495
- June 2009
- 158 pages
This report examines the growing worldwide IT software and services market for the life science and drug discovery R&D community. The broad and high-level study takes a business focus and analyzes this interesting vertical market that supports key biomedical advancements. The emergence of big-budge ...
Industries : Pharmaceutical
Production, Market and Benchmarking of Niacin in China
- $ 10 000
- June 2009
Niacin includes niconitic acid and nicotinamide and in China about 95% of niacin is nicotinamide. Niacin is widely used in feed, food and pharmaceutical industry. The key end use field for niacin is feed industry. China is the largest feed production country in the world. China's feed industry is de ...
Industries : Vitamin and Supplement, Basic Chemical
HIV Market Forecast
- $ 15 200
- June 2009
IntroductionIn 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiation, decreasing mortality and an i ...
Industries : Pharmaceutical
Frontier Pharmaceuticals Markets: Underserved And Underappreciated
- $ 745
- June 2009
...
Industries : Pharmaceutical
Slovenia Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
In BMI?s Business Environment Ranking table adjusted for Q309, Slovenia continued to improve itsposition in the Central and Eastern European (CEE) matrix and ranks 9th, up from 11th and 12th in theprevious two quarters respectively. However, the country?s improvement was due more to a decline inothe ...
Industries : Healthcare, Pharmaceutical
Forecast Insight: HIV - Cross-class fixed dose combinations drive continued growth
- $ 15 200
- June 2009
IntroductionIn 2008, antiretroviral sales across the seven major markets totaled $10.7 billion, growing at a CAGR of 12.8% between 2005 and 2008. Datamonitor expects this expansion to slow down. Despite drivers such as new product launches, earlier treatment initiation, decreasing mortality and an i ...
Industries : Pharmaceutical
Algeria Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
In BMI?s Q309 Business Environment Rankings matrix for the 17 key countries of the Middle East andAfrica (MEA) region, Algeria places 14th, above three other, much poorer African markets. While itspopulation size, privatisation status and the rising healthcare investment provide solid growthopportun ...
Industries : Healthcare, Pharmaceutical
Argentina Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
BMI calculates Argentina?s pharmaceutical expenditure to have been ARS11.5bn (US$3.71bn) in 2008.By 2013, we expect the total amount spent on prescription and OTC medicines to have reached a value ofARS38.21bn (US$6.06bn) equating to a compound annual growth rate (CAGR) of 17.8%. In US dollarterms, ...
Industries : Healthcare, Pharmaceutical
Kazakhstan Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
BMI has downgraded its US dollar forecast for the Kazakhstani pharmaceutical market sharply, in lightof a major deterioration of the tenge to US dollar exchange rate outlook for the period 2008 to 2013. Thepredicted US dollar compound annual growth rate (CAGR) for the total value of the pharmaceutic ...
Industries : Healthcare, Pharmaceutical
Peru Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
In BMI?s Q309 Business Environment Rankings matrix for the America, Peru remains second-bottom,out of 10 key markets in the region. Main drawbacks include a deficient intellectual property (IP)environment, although the February 2009 implementation of the free trade agreement (FTA) with the USshould ...
Industries : Healthcare, Pharmaceutical
South Korea Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
South Korea?s pharmaceutical market is the fourth largest in the Asia Pacific region, behind India andahead of Australia. Combined sales of prescription products and over-the-counter medicines reachedUS$9.93bn in 2008, a 5.4% increase on the previous year. In local currency terms, the market expande ...
Industries : Healthcare, Pharmaceutical
Taiwan Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Taiwan?s pharmaceutical market is the sixth largest in Asia Pacific, behind Australia and ahead ofThailand. Combined sales of prescription products and over-the-counter medicines reached US$3.58bn in2008 ? a 3.8% increase compared to the previous year. Drug spending accounts for 0.94% of GDP andannu ...
Industries : Healthcare, Pharmaceutical
Vietnam Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
The most significant impact on Vietnam?s US$1.2bn pharmaceutical market in 2009 was the full adoptionof World Trade Organization (WTO) rules. The guidelines state that foreign pharmaceutical companieshave the right to directly import and distribute their products in Vietnam. However, only those firm ...
Industries : Healthcare, Pharmaceutical
Bulgaria Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
Growth in the Bulgarian pharmaceutical market will be negatively impacted by the recession that isforecast to hit the country in 2009 and 2010 although it is proving to be more resilient than other sectors.BMI forecasts that drug market expenditure in Bulgaria should grow from US$1.09bn to US$1.16bn ...
Industries : Healthcare, Pharmaceutical
Colombia Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
In BMI?s Q309 Business Environment Ranking (BER) table for the 10 markets of the Americas,Colombia ranks sixth, down by one place from the previous quarter. The country?s sizeable population,combined with rising per capita expenditure in recent years, are important draws for pharmaceuticalinvestment ...
Industries : Healthcare, Pharmaceutical
Egypt Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
In BMI?s Q309 Business Environment Ratings table for the 17 countries in the Middle East and Africa(MEA) region, Egypt occupies an improved 11th position, up by one place in relation to the previousquarter. Despite this relatively low ranking, Egypt is placed above all other African markets, bar Sou ...
Industries : Healthcare, Pharmaceutical
France Pharmaceuticals and Healthcare Report Q3 2009
- $ 495
- June 2009
BMI calculates France?s pharmaceutical expenditure to have been EUR34.07bn (US$48.67bn) in 2008.By 2013, we expect the total amount spent on prescription and over-the-counter (OTC) medicines to havereached a value of EUR39.23bn (US$49.73bn) equating to a compound annual growth rate (CAGR) of2.9% in ...
Industries : Healthcare, Pharmaceutical
reportlinker.com © Copyright 2009. All rights reserved